With over 10 years of research experience and a PhD in Molecular and Cell Biology, I am an Associate at Cure Ventures, a leading venture capital firm that invests in early-stage biotechnology companies. At Cure Ventures, I apply my domain expertise in cell death and cancer biology to evaluate the scientific merit, market potential, and social impact of novel therapeutic approaches and technologies. I also collaborate with entrepreneurs, scientists, and investors to provide strategic guidance and support to the portfolio companies. My passion is to bridge the gap between basic research and biomedical innovation, and to contribute to the development of life-saving treatments for patients.